Venus Remedies Limited

NSE VENUSREM.NS

Venus Remedies Limited Free Cash Flow Yield on February 06, 2025: 6.24%

Venus Remedies Limited Free Cash Flow Yield is 6.24% on February 06, 2025, a 11.30% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Venus Remedies Limited 52-week high Free Cash Flow Yield is 7.86% on January 28, 2025, which is 26.11% above the current Free Cash Flow Yield.
Venus Remedies Limited 52-week low Free Cash Flow Yield is 4.96% on August 02, 2024, which is -20.37% below the current Free Cash Flow Yield.
Venus Remedies Limited average Free Cash Flow Yield for the last 52 weeks is 6.33%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

NSE: VENUSREM.NS

Venus Remedies Limited

CEO	Mr. Ashutosh Jain B.A., LL.B
IPO Date	Dec. 20, 2006
Location	India
Headquarters	Plot 51-52, Industrial Area
Employees	1,187
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Venus Remedies Limited develops and markets pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, anticoagulant, cardiac, disinfectant and antiseptic, gastro therapy, hand sanitizers, hormones, iron supplements, neurology, oncology, pain management, respiratory, skin and wound care, stress reliever, urology, and vitamins/minerals/nutrients, as well as antimicrobial resistance products. It also provides disinfectants; and a portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India.

Key trends

Past 5 years